Literature DB >> 17725983

Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.

Kurt J De Vos1,2, Anna L Chapman2, Maria E Tennant1, Catherine Manser1, Christopher C J Miller1, Andrew J Grierson2, Elizabeth L Tudor1, Kwok-Fai Lau3, Janet Brownlees1, Steven Ackerley1, Pamela J Shaw2, Declan M McLoughlin1, Christopher E Shaw1, P Nigel Leigh1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a late-onset neurological disorder characterized by death of motoneurons. Mutations in Cu/Zn superoxide dismutase-1 (SOD1) cause familial ALS but the mechanisms whereby they induce disease are not fully understood. Here, we use time-lapse microscopy to monitor for the first time the effect of mutant SOD1 on fast axonal transport (FAT) of bona fide cargoes in living neurons. We analyzed FAT of mitochondria that are a known target for damage by mutant SOD1 and also of membrane-bound organelles (MBOs) using EGFP-tagged amyloid precursor protein as a marker. We studied FAT in motor neurons derived from SOD1G93A transgenic mice that are a model of ALS and also in cortical neurons transfected with SOD1G93A and three further ALS-associated SOD1 mutants. We find that mutant SOD1 damages transport of both mitochondria and MBOs, and that the precise details of this damage are cargo-specific. Thus, mutant SOD1 reduces transport of MBOs in both anterograde and retrograde directions, whereas mitochondrial transport is selectively reduced in the anterograde direction. Analyses of the characteristics of mitochondrial FAT revealed that reduced anterograde movement involved defects in anterograde motor function. The selective inhibition of anterograde mitochondrial FAT enhanced their net retrograde movement to deplete mitochondria in axons. Mitochondria in mutant SOD1 expressing cells also displayed features of damage. Together, such changes to mitochondrial function and distribution are likely to compromise axonal function. These alterations represent some of the earliest pathological features so far reported in neurons of mutant SOD1 transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725983      PMCID: PMC4516806          DOI: 10.1093/hmg/ddm226

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  Axonal mitochondrial transport and potential are correlated.

Authors:  Kyle E Miller; Michael P Sheetz
Journal:  J Cell Sci       Date:  2004-05-18       Impact factor: 5.285

2.  JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport.

Authors:  Gerardo Morfini; Gustavo Pigino; Györgyi Szebenyi; Yimei You; Sarah Pollema; Scott T Brady
Journal:  Nat Neurosci       Date:  2006-06-04       Impact factor: 24.884

3.  The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking.

Authors:  Sa Fransson; Aino Ruusala; Pontus Aspenström
Journal:  Biochem Biophys Res Commun       Date:  2006-04-03       Impact factor: 3.575

4.  Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis.

Authors:  Shoichi Sasaki; Makoto Iwata
Journal:  J Neuropathol Exp Neurol       Date:  2007-01       Impact factor: 3.685

Review 5.  Molecular and cellular pathways of neurodegeneration in motor neurone disease.

Authors:  P J Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

6.  Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis.

Authors:  A Macho; D Decaudin; M Castedo; T Hirsch; S A Susin; N Zamzami; G Kroemer
Journal:  Cytometry       Date:  1996-12-01

7.  Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.

Authors:  Jian Liu; Concepción Lillo; P Andreas Jonsson; Christine Vande Velde; Christopher M Ward; Timothy M Miller; Jamuna R Subramaniam; Jeffery D Rothstein; Stefan Marklund; Peter M Andersen; Thomas Brännström; Ole Gredal; Philip C Wong; David S Williams; Don W Cleveland
Journal:  Neuron       Date:  2004-07-08       Impact factor: 17.173

8.  Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.

Authors:  B Zhang; P Tu; F Abtahian; J Q Trojanowski; V M Lee
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

9.  Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria.

Authors:  K De Vos; F Severin; F Van Herreweghe; K Vancompernolle; V Goossens; A Hyman; J Grooten
Journal:  J Cell Biol       Date:  2000-06-12       Impact factor: 10.539

10.  Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.

Authors:  M Tortarolo; P Veglianese; N Calvaresi; A Botturi; C Rossi; A Giorgini; A Migheli; C Bendotti
Journal:  Mol Cell Neurosci       Date:  2003-06       Impact factor: 4.314

View more
  186 in total

1.  Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.

Authors:  Yi-Bing Zhu; Zu-Hang Sheng
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 3.  Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis.

Authors:  Katharina A Quinlan
Journal:  Integr Comp Biol       Date:  2011-10-11       Impact factor: 3.326

4.  Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia.

Authors:  Yujiro Shidara; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 5.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

6.  SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse.

Authors:  Lindsey R Fischer; Anissa Igoudjil; Jordi Magrané; Yingjie Li; Jason M Hansen; Giovanni Manfredi; Jonathan D Glass
Journal:  Brain       Date:  2010-11-14       Impact factor: 13.501

Review 7.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

8.  Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.

Authors:  Arun Kumar Kondadi; Shuaiyu Wang; Sara Montagner; Nikolay Kladt; Anne Korwitz; Paola Martinelli; David Herholz; Michael J Baker; Astrid C Schauss; Thomas Langer; Elena I Rugarli
Journal:  EMBO J       Date:  2014-03-28       Impact factor: 11.598

Review 9.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 10.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.